To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
SoftBank-backed Zymergen targets $100m for U.S. IPO: Reuters
Zymergen Inc, which is backed by SoftBank Group, is seeking to raise about $100 million for its U.S. IPO, reported Reuters, citing an SEC filing.
